Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 180,000 | 185,000 | 187,700 | 205,300 | 214,400 |
| Receivables | 182,300 | 137,800 | 159,600 | 163,800 | 157,700 |
| Inventories | 184,100 | 174,100 | 153,100 | 145,900 | 144,500 |
| TOTAL | $567,600 | $517,100 | $524,100 | $538,500 | $546,500 |
| Non-Current Assets | |||||
| PPE Net | 177,300 | 179,300 | 178,700 | 184,500 | 182,100 |
| Intangibles | 971,300 | 974,800 | 979,100 | 985,200 | 990,000 |
| Other Non-Current Assets | 82,900 | 84,700 | 81,800 | 91,400 | 89,100 |
| TOTAL | $1,231,500 | $1,238,800 | $1,239,600 | $1,261,100 | $1,261,200 |
| Total Assets | $1,799,100 | $1,755,900 | $1,763,700 | $1,799,600 | $1,807,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 75,900 | 75,800 | 73,500 | 83,000 | 94,700 |
| Accrued Expenses | 87,900 | 84,800 | 101,600 | 114,800 | 108,900 |
| TOTAL | $179,400 | $176,000 | $189,400 | $212,500 | $218,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 248,500 | 248,400 | 248,200 | 248,100 | 247,900 |
| Other Non-Current Liabilities | 67,500 | 69,900 | 69,600 | 73,800 | 74,300 |
| TOTAL | $329,800 | $318,300 | $317,800 | $321,900 | $322,700 |
| Total Liabilities | $509,200 | $494,300 | $507,200 | $534,400 | $540,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,833 | 47,832 | 47,757 | 47,755 | 47,929 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -268,300 | -287,600 | -284,600 | -288,300 | -282,200 |
| Other shareholders' equity | -37,400 | -42,200 | -46,800 | -31,900 | -34,500 |
| TOTAL | $1,289,900 | $1,261,600 | $1,256,500 | $1,265,200 | $1,266,900 |
| Total Liabilities And Equity | $1,799,100 | $1,755,900 | $1,763,700 | $1,799,600 | $1,807,700 |